Calling All Superheroes!

Tarlton Open House and Cancer Awareness Forum

Calling All Superheroes is Tarlton’s tribute to the unsung heroes: the exemplary physicians, brave patients, innovative life science and bio tech researchers both at Stanford and here at Menlo Park Labs.


Under Special Instructions enter:
IHO Tarlton Properties




Cancer Superheroes

John Tarlton, MBA

CEO of Tarlton Properties


John Tarlton brings vision and innovation to his role as CEO of Tarlton Properties. Commercial real estate is in his DNA. He is an engineer by training, an astute businessman by education, and an ultra racing enthusiast. In his current role, he has managed more than 2 M square feet of prime Silicon Valley assets valued at more than $900M. At Menlo Park Labs, where others saw industrial warehouses, John saw the potential to build a vibrant biotech science center to support collaboration between local researchers, entrepreneurs, and investors. When tragedy struck his family, and his mother and sister were lost to cancer, John began to focus his philanthropic efforts on raising awareness of cancer prevention and in supporting the development of new cancer therapies. The Stanford Cancer Institute (SCI) was a natural choice for his giving because of the expert care his family had received at Stanford. As one of fewer than 300 to successfully complete solo in the Race Across America (RAAM), John continues his joint commitment to ultra racing and raising funds and awareness for SCI by participating in Ironman triathlons, marathons and other ultra running events. He is currently cross training for another solo RAAM run in 2019.


Oliver Dorigo, MD, PhD

Associate Professor of Obstetrics & Gynecology - Gynecologic Oncology. He is a member of the Stanford Cancer Institute and Bio-X.


Oliver Dorigo, MD, PhD is the director of the Gynecologic Oncology Service at the Stanford Medical Center and the Stanford Women’s Cancer Center. He is a gynecologic surgeon as well as a molecular biologist conducting laboratory and clinical research into immunological and targeted molecular therapies to treat ovarian cancer. At Stanford, he has had a tremendous impact on both the research and clinical care aspects of ovarian cancer treatment.

Dr. Dorigo received his medical degree from the University of Heidelberg and then did his residency at Ludwig Maximillians University in Munich. He then moved to the University of California, Los Angeles in 1995 to pursue clinical training in obstetrics, gynecology, and gynecologic oncology. While there he obtained a PhD in molecular biology. After seven years as a UCLA faculty member, he was recruited by the Stanford Medical Center.


Deborah Goldberg, JD

Cancer Ambassador and Stage IV Colon Cancer Warrior


Deborah Goldberg grew up in Portland, Oregon where she met her childhood sweetheart, a German exchange student. They have been married for 22 years and have 3 amazing children. She received a BA from Brown University and a JD from UCLA. She achieved career success practicing law. Then, after loosing her beloved mother and mother-in-law to cancer, she was diagnosed with Stage IV cancer and has been a patient at the Stanford Cancer Center since 2014. Today, Deborah is LIVING with not despite cancer. She will discuss how hope conquers fear and how important the Stanford Cancer Institute doctors and researchers have been to her. Her secret childhood dream: to be Wonder Woman.


Jan Liphardt, PhD

Associate Professor of Bioengineering at the Stanford Schools of Engineering and Medicine and founder of the Liphardt Lab. He is also a member of Bio-X.


Jan Liphardt, PhD specializes in biophysics, the tumor microenvironment, and data analysis.

During his 2016 State of the Union address, President Barack Obama called on Vice President Joe Biden – who had months earlier lost his son Beau to brain cancer – to head a “moonshot” to significantly accelerate research into the disease. The president said he wanted to harness the spirit of American innovation that took us from zero to landing a man on the moon in a decade to similarly find new ways to prevent, diagnose, and treat cancer. Dr Liphardt is one of the distinguished researchers called upon to make this dream a reality.

Dr. Liphardt is a Searle Scholar, a Sloan Research Fellow, a Hellman Fellow, and the recipient of the 2007 Mohr Davidow Ventures Innovator’s Award. He received a BA from Reed College and a PhD from Cambridge University. After 2 years as a joint postdoc in the labs of Carlos Bustamante and Nacho Tinoco Jr, he became the divisional fellow of the Physical Biosciences Division at Lawrence Berkeley National Lab. He joined the Berkeley Physics faculty in 2004 and later moved to Stanford.


Elaine Cheung, MS

Director of Business Development, GRAIL


Elaine Cheung leads business development, and is a founding team member, at GRAIL, Inc. Previously, she was the Director of Strategic Partnerships, as well as Director of Business Development, at Illumina, the leading provider of next generation sequencing technologies. She was focused on strategy and transactions to enable clinical adoption of NGS in Oncology, Reproductive Health and Transplant Medicine. Elaine also spent six years at Genomic Health, which develops and commercializes Oncotype Dx™ to help guide treatment decisions for breast, colorectal and prostate cancer patients. Elaine earned a BS in Biological Sciences and an MS in Management Science & Engineering, both from Stanford University, where she was also a Mayfield Fund Fellow.




Under Special Instructions enter:
IHO Tarlton Properties


Our expanded corporate offices mark a new stage in our growth. As we continue to foster an environment of collaboration among our tenants and neighbors, this celebration provides a great opportunity to raise awareness about cancer research and inspire support for the Stanford Cancer Institute.




Phone: (650) 330-3600